Moat Ross bought KNSA
November 2, 2026 · Form 4 insider transaction
Moat Ross bought 6,263 shares of Kiniksa Pharmaceuticals International, plc at $22.89 per share, a transaction worth $143.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,263
Price
$22.89
Total value
$143.4K
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateNovember 2, 2026
Filing dateNovember 3, 2026
Shares owned after38,271
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 29, 2026.